Behind the Sella: A Rare Case of Pituicytoma Mimicking a Pituitary Adenoma.
- 1Clinic of Endocrinology, Diabetology and Internal Medicine, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Olsztyn, Poland.
Abstract
BACKGROUND Pituicytoma is a rare central nervous system (CNS) World Health Organization (WHO) grade I glioma originating from pituicytes, the specialized glial cells of the neurohypophysis or infundibulum. It accounts for less than 0.1% of all sellar and suprasellar masses and often presents a diagnostic challenge because of its clinical and radiological resemblance to other pituitary lesions. CASE REPORT A 48-year-old man was admitted to the endocrinology clinic because of clinical symptoms of hypogonadism, headaches, and visual field defects. Hormonal evaluation revealed hypogonadotropic hypogonadism and hyperprolactinemia. Magnetic resonance imaging (MRI) demonstrated a sellar-suprasellar mass, initially suggestive of prolactinoma. Lack of response to initial hormone replacement therapy, progressive tumor enlargement, and worsening visual impairment, prompted surgical resection via a right-temporal craniotomy. Histopathological and immunohistochemical examination established the diagnosis of pituicytoma (CNS WHO Grade 1). The postoperative course was complicated by transient cognitive impairment and endocrine deficiencies requiring long-term hormonal replacement therapy. We also review the epidemiology, clinical presentation, and current therapeutic approaches for this uncommon tumor. CONCLUSIONS Pituicytoma is a rare benign tumor that may closely mimic pituitary adenoma, both clinically and radiologically. Clinical manifestations are non-specific and primarily reflect tumor size and local extension. MRI findings are not pathognomic, making histopathological confirmation essential. Surgical resection remains the treatment of choice, whereas radiotherapy may be considered after subtotal resection. The case underscores the importance of recognizing hyperprolactinemia secondary to pituitary stalk compression, careful endocrine interpretation, individualized surgical planning, and prolonged multidisciplinary follow-up, given the uncertain long-term prognosis and potential endocrine sequelae.
Related
- Resistance to Thyroid Hormone Beta or Thyroid-Stimulating Hormone (TSH)-Secreting Pituitary Adenoma: A Diagnostic Dilemma With a THRB Variant of Uncertain Significance
- Predictive Factors for Diabetes Insipidus and Syndrome of Inappropriate Secretion of Antidiuretic Hormone After Transsphenoidal Surgery for Pituitary Adenoma
- Acute visual deterioration following endoscopic transsphenoidal resection of a pituitary adenoma secondary to a de novo cyst of normal pituitary origin: illustrative case
- Tumor-to-tumor metastasis of colorectal adenocarcinoma within a gonadotroph pituitary adenoma.
- Tirzepatide for pasireotide-induced hyperglycemia in a GH/TSH-producing pituitary adenoma/PitNET: a case report and literature review
BibTeX
@article{wolosklosowicz2026behind,
title = {{Behind the Sella: A Rare Case of Pituicytoma Mimicking a Pituitary Adenoma.}},
author = {Katarzyna Wołos-Kłosowicz and Nina Suligowska-Wolszczuk and Michał Szklarz and Joanna Rutkowska and Wojciech Matuszewski},
journal = {The American journal of case reports},
year = {2026},
month = oct,
doi = {10.12659/ajcr.953658},
url = {https://europepmc.org/article/MED/42879325},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Behind the Sella: A Rare Case of Pituicytoma Mimicking a Pituitary Adenoma.
AU - Katarzyna Wołos-Kłosowicz
AU - Nina Suligowska-Wolszczuk
AU - Michał Szklarz
AU - Joanna Rutkowska
AU - Wojciech Matuszewski
PY - 2026
DA - 2026/10/15
JO - The American journal of case reports
DO - 10.12659/ajcr.953658
UR - https://europepmc.org/article/MED/42879325
AB - BACKGROUND Pituicytoma is a rare central nervous system (CNS) World Health Organization (WHO) grade I glioma originating from pituicytes, the specialized glial cells of the neurohypophysis or infundibulum. It accounts for less than 0.1% of all sellar and suprasellar masses and often presents a diagnostic challenge because of its clinical and radiological resemblance to other pituitary lesions. CASE REPORT A 48-year-old man was admitted to the endocrinology clinic because of clinical symptoms of hypogonadism, headaches, and visual field defects. Hormonal evaluation revealed hypogonadotropic hypogonadism and hyperprolactinemia. Magnetic resonance imaging (MRI) demonstrated a sellar-suprasellar mass, initially suggestive of prolactinoma. Lack of response to initial hormone replacement therapy, progressive tumor enlargement, and worsening visual impairment, prompted surgical resection via a right-temporal craniotomy. Histopathological and immunohistochemical examination established the diagnosis of pituicytoma (CNS WHO Grade 1). The postoperative course was complicated by transient cognitive impairment and endocrine deficiencies requiring long-term hormonal replacement therapy. We also review the epidemiology, clinical presentation, and current therapeutic approaches for this uncommon tumor. CONCLUSIONS Pituicytoma is a rare benign tumor that may closely mimic pituitary adenoma, both clinically and radiologically. Clinical manifestations are non-specific and primarily reflect tumor size and local extension. MRI findings are not pathognomic, making histopathological confirmation essential. Surgical resection remains the treatment of choice, whereas radiotherapy may be considered after subtotal resection. The case underscores the importance of recognizing hyperprolactinemia secondary to pituitary stalk compression, careful endocrine interpretation, individualized surgical planning, and prolonged multidisciplinary follow-up, given the uncertain long-term prognosis and potential endocrine sequelae.
SN - 1941-5923
ER -